Medtronic (MDT) Capital Leases (2014 - 2018)

Medtronic has disclosed Capital Leases across 5 years of filings, most recently posting $21.0 million for Q2 2018.

• Capital Leases for Q2 2018 came in at $21.0 million, down 8.7% year-over-year; the trailing twelve-month figure through Apr 2018 was $21.0 million (down 8.7% YoY), and the FY2018 annual result was $21.0 million, down 8.7% from the prior year.
• Capital Leases came in at $21.0 million for Q2 2018 at Medtronic, down from $23.0 million in the prior quarter.
• In the past five years, Capital Leases ranged from a high of $139.0 million in Q2 2014 to a low of $21.0 million in Q2 2018.
• The 5-year median for Capital Leases is $27.0 million (2016), against an average of $70.6 million.
• Across the five-year window, Capital Leases declined 7.19% in 2015 and sank 80.0% in 2016, its largest moves.
• Medtronic's Capital Leases stood at $139.0 million in 2014, then slipped by 12.95% to $121.0 million in 2015, then plunged by 77.69% to $27.0 million in 2016, then decreased by 14.81% to $23.0 million in 2017, then dropped by 8.7% to $21.0 million in 2018.
• The last three Capital Leases figures came in at $21.0 million (Q2 2018), $23.0 million (Q2 2017), and $24.0 million (Q1 2017), per Business Quant data.